trending Market Intelligence /marketintelligence/en/news-insights/trending/82eGyZwX55dYJoX-SmsM7A2 content esgSubNav
In This List

Tandem Diabetes plans common stock, warrants offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Tandem Diabetes plans common stock, warrants offering

Tandem Diabetes Care Inc. plans to offer and sell its common shares, series A warrants and series B warrants to buy common shares in an underwritten public offering.

The company plans to use the net proceeds for working capital and other general corporate purposes.

Oppenheimer & Co. Inc. is acting as the sole book-running manager and National Securities Corp. is acting as a co-manager for the offering.